Potential side effects may include injection-site redness, swelling, bruising, itching, tenderness, small lumps, headache, fatigue, nausea, appetite changes, abdominal discomfort, stool changes, dizziness, altered sleep, mood changes, or feeling off. Allergic or immune reactions are also possible, and the FDA has specifically raised concerns about immunogenicity and peptide-related impurities in compounded BPC-157
It carries a pharmaceutical generic name, prezatide copper acetate (Iamin), and the formulation that reached controlled human testing under that name was a topical gel but no approval followed
For psoriasis, subcutaneous injection offers several advantages
Tesamorelins midsection fat-burning properties are complemented by Ipamorelins growth hormone support for muscle preservation